bexarotene has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, P; Huan, H; Liu, Z; Lu, Z; Wang, M; Wang, W; Wu, B; Yang, C | 1 |
| Akasov, R; Akimov, MG; Bezuglov, VV; Burov, S; Dudina, PV; Gamisonia, AM; Gretskaya, NM; Markvicheva, E; Serkov, IV; Sherstyanykh, G; Zakharov, SS | 1 |
| Hacioglu, C; Kacar, S; Kanbak, G; Kar, F; Sahinturk, V | 1 |
3 other study(ies) available for bexarotene and Glioma
| Article | Year |
|---|---|
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Topics: Apoptosis; Bexarotene; Bortezomib; Brain Neoplasms; Class I Phosphatidylinositol 3-Kinases; Copper; Cytarabine; DNA-Binding Proteins; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Prognosis; RNA-Binding Proteins; Tumor Microenvironment | 2022 |
Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bexarotene; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Glioma; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasm Invasiveness; Rats; Spheroids, Cellular; Structure-Activity Relationship | 2020 |
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bexarotene; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; Glioma; NF-kappa B; Oxidative Stress; PPAR gamma; Rats; Retinoid X Receptors; Signal Transduction | 2021 |